| 1 |
Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial [J]. JAMA, 2017, 318(14): 1335-1345.
|
| 2 |
Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome [J]. N Engl J Med, 2018, 378(21): 1965-1975.
|
| 3 |
Hardin CC, Hibbert K. ECMO for severe ARDS [J]. N Engl J Med, 2018, 378(21): 2032-2034.
|
| 4 |
Harrington D, Drazen JM. Learning from a trial stopped by a Data and Safety Monitoring Board [J]. N Engl J Med, 2018, 378(21): 2031-2032.
|
| 5 |
Shanholtz C, Reed RM, Brower RG. ECMO for severe acute respiratory distress syndrome [J]. N Engl J Med, 2018, 379(11): 1090.
|
| 6 |
Patel BV, Barrett NA, Vuylsteke A. ECMO for severe acute respiratory distress syndrome [J]. N Engl J Med, 2018, 379(11): 1090-1091.
|
| 7 |
Muñoz J, Keough EA, Visedo LC. ECMO for severe acute respiratory distress syndrome [J]. N Engl J Med, 2018, 379(11): 1091.
|
| 8 |
Bartlett RH. Extracorporeal membrane oxygenation for acute respiratory distress syndrome: EOLIA and beyond [J]. Crit Care Med, 2019, 47(1): 114-117.
|
| 9 |
Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial [J]. JAMA, 2019, 321(7): 654-664.
|
| 10 |
Munch MW, Myatra SN, Vijayaraghavan BKT, et al. Effect of 12 mg vs 6 mg of Dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial [J]. JAMA, 2021, 326(18): 1807-1817.
|
| 11 |
Greenland S, Senn SJ, Rothman KJ, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations [J]. Eur J Epidemiol, 2016, 31(4): 337-350.
|
| 12 |
Goligher EC, Tomlinson G, Hajage D, et al. extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post Hoc Bayesian analysis of a randomized clinical trial [J]. JAMA, 2018, 320(21): 2251-2259.
|
| 13 |
Zampieri FG, Damiani LP, Bakker J, et al. Effects of a resuscitation strategy targeting peripheral perfusion status versus serum lactate levels among patients with septic shock. A Bayesian reanalysis of the ANDROMEDA-SHOCK trial [J]. Am J Respir Crit Care Med, 2020, 201(4): 423-429.
|
| 14 |
Granholm A, Munch MW, Myatra SN, et al. Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial [J]. Intensive Care Med, 2022, 48(1): 45-55.
|
| 15 |
Yarnell CJ, Abrams D, Baldwin MR, et al. Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making? [J]. Lancet Respir Med, 2021, 9(2): 207-216.
|